Why the Polynovo share price rocketed 27% higher today

The Polynovo Ltd (ASX:PNV) share price is rocketing higher on Friday. Here's why its shares were up 27% at one stage…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Polynovo Ltd (ASX: PNV) share price is ending the week on a very positive note.

In early afternoon trade the medical device company's shares are the best performers on the ASX 200 with a 17.5% gain to $2.04.

At one stage the Polynovo share price was up as much as 27% to $2.20.

When its shares reached that level, it meant they were up an incredible 266% since the start of the year.

Why is the Polynovo share price rocketing higher today?

Investors have been fighting to get hold of its shares after a positive announcement relating to its NovoSorb BTM product.

The NovoSorb BTM product is a dermal scaffold for the regeneration of the dermis when lost through extensive surgery or burn.

This morning the company announced that it has been granted certificate of conformance (CE Mark) approval for sale throughout the UK/Ireland and the European Union.

It has been approved for use in all full dermal loss procedures. This includes full thickness burns, trauma, reconstructive surgery, and diabetic foot ulcers.

What now?

PolyNovo advised that it will now need to file documents with each European market. However, this is a routine administrative function and will not delay sales and shipments.

PolyNovo CEO, Paul Brennan, said: "This is a watershed moment for PolyNovo. Our global regulatory approvals have expanded significantly with this certification. Our early preparedness in UK/Ireland and DACH should mean a shortened timeline to booking our first sale. We also believe CE approval will fast track regulatory approval in a number of other countries including several in South East Asia".

This sentiment was echoed by PolyNovo's chairman, David Williams. He said: "We are confident we will have early sales in the UK/Ireland and in Germany through PMI. We will now quickly expand our direct sales force in other parts of the EU."

Elsewhere, the Next Science Ltd (ASX: NXS) share price is racing higher today. The medical technology company's are up 8% after being granted its first acne-related patent.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

Stock market chart in green with a rising arrow symbolising a rising share price.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a massive day for the ASX 200, with a new all-time high recorded.

Read more »

A man sits thoughtfully on the couch with a laptop on his lap.
Technology Shares

This ASX tech stock rocketed 60% in March! Can it keep on delivering?

After soaring in March, the ASX tech stock is now up 169% since this time last year.

Read more »

A young women pumps her fists in excitement after seeing some good news on her laptop.
Share Gainers

Why Mesoblast, Newmont, Pilbara Minerals, and Platinum shares are jumping

These ASX shares are ending the week strongly. But why?

Read more »

A young male ASX investor raises his clenched fists in excitement because of rising ASX share prices today
Share Gainers

3 ASX All Ords shares up 50%+ in March

These ASX shares have been on fire this month. But why?

Read more »

Woman looks amazed and shocked as she looks at her laptop.
Share Gainers

Why Mesoblast, Patriot Battery Metals, Sigma, and Zip shares are pushing higher

These shares are having a good session on hump day. But why?

Read more »

Woman looks amazed and shocked as she looks at her laptop.
Consumer Staples & Discretionary Shares

If you'd put $20,000 in this ASX retail stock at the start of 2023, you'd have $134,000 now

This online retailer has executed a remarkable turnaround for its investors.

Read more »

Fancy font saying top ten surrounded by gold leaf set against a dark background of glittering stars.
Share Gainers

Here are the top 10 ASX 200 shares today

It was back to earth for ASX shares this Tuesday.

Read more »

Two happy scientists analysing test results.
Healthcare Shares

Mesoblast share price rockets 36% on breaking FDA news

ASX investors are sending the Mesoblast share price soaring following promising FDA news.

Read more »